bioRxivCancer BiologyPreprint
Simulations on the efficacy of radiotherapy with different time schemes of antiangiogenic therapy
Abstract
The combination of radiotherapy and antiangiogenic agents has been suggested to be potent in tumor growth control compared to the application of antiangiogenic therapy or radiotherapy alone. Since radiotherapy is highly dependent on the oxygen level of the tumor area, antiangiogenic agents are utilized for the reoxygenation of tumor vasculature. We present a mathematical framework to investigate the efficacy of radiotherapy combined with antiangiogenic treatment. The framework consists of tumor cells, vasculature, and oxygenation levels evolving with time to mimic a tumor microenvironment. Non-linear partial differential equations (PDEs) are employed to simulate each component of the framework. Different treatment schemes are investigated to see the changes in tumor growth and oxygenation. To test combination schedules, radiation monotherapy, neoadjuvant, adjuvant, and concurrent cases are simulated. The efficiency of each therapy scheme on tumor growth control, the changes in tumor cell density, and oxygen levels shared by tumor cells are represented. The simulation results indicate that the application of radiotherapy after antiangiogenic treatment is more efficient in tumor growth control compared to other therapy schemes. The present study gives an insight into the possible interaction and timing of the combination of radiotherapy and antiangiogenic drug treatment.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modeling of chemo-radiotherapy targeting growing vascular tumors: a continuum-level approach
I. A. Lampropoulos, M. Koutsi, M. Kavousanakis·bioRxiv·Mar 21, 2024
- Multi-scale modeling reveals angiogenesis-induced drug resistance in brain tumor and predicts a synergistic drug combination targeting EGFR and VEGFR pathways
Weishan Liang, Yongjiang Zheng, … Xiaoqiang Sun·BMC BioinformaticsPeer-reviewed·Apr 30, 2019
- The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment
Ding Li, Stacey D. Finley·Integrative BiologyPeer-reviewed·Apr 1, 2018
- Multiscale modeling of tumor adaption and invasion following anti-angiogenic therapy
Colin G. Cess, Stacey D. Finley·Computational and Systems OncologyPeer-reviewed·Feb 21, 2022
- Enhanced perfusion following exposure to radiotherapy: a theoretical investigation
Jakub Köry, Vedang Narain, … Helen Mary Byrne·PLoS Computational BiologyPeer-reviewed·Feb 16, 2024
- Microvascular morphology affects radiotherapy outcomes: a computational study
L. Possenti, P. Vitullo, … T. Rancati·bioRxiv·Oct 16, 2023